Table 2 Clinicopathological characteristics of the WEA cohort.

From: Circulating microRNA-197-3p as a potential biomarker for asbestos exposure

Diseases, not related to asbestos

Yes/no

N (%)

Musculoskeletal diseases (yes/no)

Yes

7 (9.3)

No

57 (76.0)

N/A

11 (14.7)*

Cardiovascular diseases (yes/no)

Yes

29 (38.7)

No

35 (46.7)

N/A

11 (14.7) *

Gastrointestinal diseases (yes/no)

Yes

10 (13.3)

No

54 (72.0)

N/A

11 (14.7) *

Endocrine diseases (yes/no)

Yes

20 (26.7)

No

44 (58.7)

N/A

11 (14.7) *

Respiratory diseases (yes/no)

Yes

15 (20.0)

No

49 (65.3)

N/A

11 (14.7) *

Neurological diseases (yes/no)

Yes

5 (6.7)

No

59 (78.7)

N/A

11 (14.7)*

Genitourinary diseases (yes/no)

Yes

11 (14.7)

No

53 (70.7)

N/A

11 (14.7)*

Neoplastic diseases (yes/no)

Yes

10 (13.3)

No

54 (72.0)

N/A

11 (14.7)*

Therapy (yes/no)

Yes

57 (76.0)

No

18 (24.0)

N/A

0

  1. *Data available for 64 out of 75 (85.3%) subjects.